UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000039279
Receipt No. R000044800
Scientific Title Survey on integrative medicine utilization and attitude in Japanese local government staffs for disease prevention and health promotion program
Date of disclosure of the study information 2020/02/01
Last modified on 2020/08/02 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments

Basic information
Public title Survey on integrative medicine utilization and attitude in Japanese local government staffs for disease prevention and health promotion program
Acronym Survey on integrative medicine utilization in Japanese local governments
Scientific Title Survey on integrative medicine utilization and attitude in Japanese local government staffs for disease prevention and health promotion program
Scientific Title:Acronym Survey on integrative medicine utilization in Japanese local governments
Region
Japan

Condition
Condition General population
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the current state of integrated medical care in Japanese local governments
Basic objectives2 Others
Basic objectives -Others To clarify the attitudes for disease prevention and health promotion using integrated medical care in Japanese local government stuffs
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Actual utilization
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Local government stuffs with experience of integrated medicine use for local citizens
Key exclusion criteria None
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Ichiro
Middle name
Last name ARAI
Organization Nihon Pharmaceutical University
Division name Department of Pharmaceutical Science
Zip code 362-0806
Address 10281, Komuro, Ina, Kitaadachi, Saitama, 362-0806
TEL 048-721-1155
Email i-arai@nichiyaku.ac.jp

Public contact
Name of contact person
1st name Ichiro
Middle name
Last name Arai
Organization Nihon Pharmaceutical University
Division name Department of Pharmaceutical Science
Zip code 362-0806
Address 10281, Komuro, Ina, Kitaadachi, Saitama
TEL 048-721-1155
Homepage URL
Email i-arai@nichiyaku.ac.jp

Sponsor
Institute Nihon Pharmaceutical University
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor National Institute of Public Health
Name of secondary funder(s)

IRB Contact (For public release)
Organization Nihon Pharmaceutical University
Address 10281, Komuro, Ina, Kitaadachi, Saitama
Tel 048-721-1155
Email i-arai@nichiyaku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 02 Month 01 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled 12
Results 
An interview survey was conducted with a person in charge of a local disease prevention/health promotion program regarding the feasibility of a social model of integrated medicine. 11 out of 12 people answered that integrated medicine is useful for improving the health of local residents, but it is necessary to prove its effectiveness.
Results date posted
2020 Year 08 Month 02 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 12 Month 23 Day
Date of IRB
2019 Year 12 Month 23 Day
Anticipated trial start date
2020 Year 01 Month 21 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
2020 Year 03 Month 31 Day
Date trial data considered complete
2020 Year 03 Month 31 Day
Date analysis concluded
2020 Year 03 Month 31 Day

Other
Other related information Interview

Management information
Registered date
2020 Year 01 Month 28 Day
Last modified on
2020 Year 08 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044800